Use of amantadine in a patient with SARS‐CoV‐2
Open Access
- 15 June 2020
- journal article
- letter
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (1), 110-111
- https://doi.org/10.1002/jmv.26179
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effectsJournal of Medical Virology, 2020
- Amantadine as a drug to mitigate the effects of COVID-19Medical Hypotheses, 2020
- Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical TrialJAMA Network Open, 2020
- Does amantadine have a protective effect against COVID-19?Neurologia i Neurochirurgia Polska, 2020